Figure 3.
Figure 3. Effect of DHG on the in vitro half-life of factor VIIIa. Recombinant factor VIII (20 nM) was activated for 30 seconds with 40 nM thrombin, neutralized with 60 nM hirudin, and immediately diluted 1:2 into the tenase reaction buffer in the absence (•) or presence of 25 (○) or 50 nM (▪) DHG. Residual factor VIIIa activity was determined by sampling into the intrinsic tenase assay as described (see “Materials and methods”) and the data fit to a simple exponential decay. Mean values for factor VIIIa activity were plotted versus time with error bars representing ± SD (n = 3). The kobs for loss of factor VIIIa activity was 0.16 min–1 for cofactor alone and 0.18 min–1 or 0.19 min–1 for cofactor plus 25 or 50 nM nM DHG, respectively.

Effect of DHG on the in vitro half-life of factor VIIIa. Recombinant factor VIII (20 nM) was activated for 30 seconds with 40 nM thrombin, neutralized with 60 nM hirudin, and immediately diluted 1:2 into the tenase reaction buffer in the absence (•) or presence of 25 (○) or 50 nM (▪) DHG. Residual factor VIIIa activity was determined by sampling into the intrinsic tenase assay as described (see “Materials and methods”) and the data fit to a simple exponential decay. Mean values for factor VIIIa activity were plotted versus time with error bars representing ± SD (n = 3). The kobs for loss of factor VIIIa activity was 0.16 min–1 for cofactor alone and 0.18 min–1 or 0.19 min–1 for cofactor plus 25 or 50 nM nM DHG, respectively.

Close Modal

or Create an Account

Close Modal
Close Modal